Page 379 - Binder2
P. 379
the idea that complexity equals value—and embrace a
future where delivery is designed for dignity, not
dependency.
Why the Infrastructure Was Never Designed for
Access
Let’s be blunt: the infrastructure surrounding biologic
drugs was never built for the benefit of patients. It was
engineered—carefully, incrementally, and often
profitably—to manage liability, preserve exclusivity, and
create defensible pricing models. The patient experience
was never the focal point. It was an afterthought, dressed
up in language about safety and precision.
From the earliest days of monoclonal antibodies to today’s
sprawling network of infusion centers, specialty
pharmacies, and temperature-controlled logistics, the
biologic delivery system has always served a deeper
function: to transform therapeutic complexity into
financial value.
And the friction? The need for infusion appointments, the
endless insurance forms, the cold-chain dependencies, the
specialist gatekeeping?
That wasn’t a failure of design.
That was the design.
377
